Conference Call and Webcast Today at 4:30 p.m. ET Development Program Highlights and Anticipated Milestones Ovaprene® hormone-free monthly intravaginal contraceptive candidate - pivotal Phase 3 contra ...
With the ever-growing popularity of digital art, Android users now have access to a wide range of drawing apps that cater to ...